Your browser doesn't support javascript.
loading
A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men.
Zhang, Hong; Wang, Hong; Wei, Haijing; Chen, Hong; Liu, Jingrui; Li, Cuiyun; Zhu, Xiaoxue; Li, Xiaojiao; Yu, Jinchen; Zhou, Yinbo; Yang, Xiaolei; Wang, Zhaohe; Wu, Min; Ding, Yanhua.
Afiliação
  • Zhang H; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Wang H; Jilin Medical Products Administration, Jilin, China.
  • Wei H; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Chen H; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Liu J; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Li C; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Zhu X; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Li X; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Yu J; Bio-Thera Solutions, Ltd. Guang Zhou, Guangdong, China.
  • Zhou Y; Bio-Thera Solutions, Ltd. Guang Zhou, Guangdong, China.
  • Yang X; Bio-Thera Solutions, Ltd. Guang Zhou, Guangdong, China.
  • Wang Z; Bio-Thera Solutions, Ltd. Guang Zhou, Guangdong, China.
  • Wu M; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
  • Ding Y; Phase I Clinical Research Center, The First Hospital of Jilin University, Jilin, China.
Front Pharmacol ; 11: 609522, 2020.
Article em En | MEDLINE | ID: mdl-33569002

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2020 Tipo de documento: Article